1997•European Journal of PharmacologyRequires access

Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors

Marilenna Kampa, Efstathia Bakogeorgou, Anastassia Hatzoglou, Athina Damianaki, Pierre‐Marie Martin, Elias Castanas

Open publisher page 110 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 110 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Diprenorphine, Etorphine, LNCaP, DADLE, Enkephalin, Endocrinology, DU145, Internal medicine

Back to paper search Browse research topics Original source

Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors — Research Paper | ScholarLens